SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Novartis India

Novartis India

BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Oct 23, 17:00
654.25
10.75 (+1.67%)
VOLUME 4,408
AVERAGE VOLUME
5-Day 6,604
10-Day 10,798
30-Day 21,650
VOLUME SHOCKER
5-Day 6,604
10-Day 10,798
30-Day 21,650
Prev. Close
643.50
Open Price
649.70
Bid PRICE (QTY.)
654.25 (105)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 645.10 659.90
52 Wk Low/High 394.50 760.00

Novartis India is not traded on NSE in the last 30 days

Action in Novartis India

Novartis India
Sentimeter

100%
BUY

100% of moneycontrol users recommend buying Novartis India. What's your call on Novartis India today?
Read Investor view

MARKET CAP (Rs Cr)
2,091.04
*P/E
21.13
*BOOK VALUE (Rs)
300.79
DIV (%)
200.00%
Market Lot
1
INDUSTRY P/E
22.82
*EPS (TTM)
30.97
*P/C
20.38
*PRICE/BOOK
2.18
DIV YIELD.(%)
1.53%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
74.43 new
DELIVERY AVERAGES
3-Day 69.19%
5-Day 71.73%
8-Day 70.96%
* Based on standalone numbers
Track Novartis India on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

21 October 2014

buy

JubilantFood Oct Fut

Entry Price (Rs)

1,220.00

Exit Price (Rs)

1,242.00

Gain (Rs)

22.00

buy

RelCapital Oct Fut

Entry Price (Rs)

453.70

Exit Price (Rs)

461.00

Gain (Rs)

7.00

buy

TitanCompany Oct Fut

Entry Price (Rs)

389.00

Exit Price (Rs)

394.00

Gain (Rs)

5.00

buy

SesaSterlite Oct Fut

Entry Price (Rs)

245.50

Exit Price (Rs)

250.00

Gain (Rs)

4.00

buy

ACC Oct Fut

Entry Price (Rs)

1,422.00

Exit Price (Rs)

1,439.00

Gain (Rs)

17.00

buy

IndiaCements Oct Fut

Entry Price (Rs)

107.75

Exit Price (Rs)

111.00

Gain (Rs)

3.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 409.00 649.70  
High Price 409.00 659.90  
Low Price 397.50 645.10  
Last Price 398.40 654.25 64.22
Volume 6,103 4,408 -27.77
Simple Moving Averages
Days BSE NSE
30 683.22
50 678.43
150 578.86
200 540.52

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Novartis India

The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
Pre Opening Session Prices 9:00 - 9:15
BSE - No shares traded
NSE - No shares traded
News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Standalone (Jun '14)
(Mar '14)
Net Sales 202.06 193.03
Other Income 24.87 25.81
PBDIT 21.73 33.17
Net Profit 14.31 23.88

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Mar '14)
(In Rs Cr)
Total Share Capital 15.98
Net Worth 961.35
Total Debt 0.00
Net Block 7.87
Investments 0.03
Net Current Assets 953.45
Total Assets 961.35
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 810.15 0.40 877.40 552.50 167,795.34
Lupin 1391.55 0.23 1442.30 841.10 62,486.39
Dr Reddys Labs 3054.35 0.54 3353.85 2250.00 52,035.69
Cipla 628.45 0.25 639.05 366.70 50,459.59
Cadila Health 1377.50 0.75 1397.75 650.00 28,204.11
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 14Dec' 13Sep' 13Jun' 13
Promoter75.0075.0075.0075.00
FII1.862.002.112.33
DII1.661.541.231.08
Others21.4821.4621.6621.59
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Sandoz House, Shivsagar Estate, Dr Annie Besant Road,,Worli
City
Mumbai
State
Maharashtra
Pin Code
400018
Tel. No.
022-24958400 022-24958888
Fax No.
24950221
REGISTRARS
Name
Sharepro Services (India) Pvt.Ltd.
Address
13 AB, Samhita Warehousing Complex, 2nd Floor, Sakinaka Telephone Exchange Lane, Off Andheri-Kurla Road, Sakinaka, Andheri (E)
City
Mumbai - 400072
State
Maharashtra
Tel. No.
022-67720300, 67720400
Fax No.
022-28591568, 28508927
MANAGEMENT
Name
Designation
Christopher Snook
Chairman
Ranjit Shahani
Vice Chairman & Mng.Director
Jai Hiremath
Director
Rajendra Nath Mehrotra
Director
Manisha Girotra
Additional Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

RS Software (India) Recommended on Aug 12th 2014

Recommended price 430.00  |  Peak from reco 830.00 93.02%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Novartis India

Novartis India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,091.04 crore.The company has reported a standalone sales of Rs 202.06 crore and a Net Profit of Rs 14.31 crore for the quarter ended Jun 2014.

The company management includes Christopher Snook - Chairman, Ranjit Shahani - Vice Chairman & Mng.Director, Jai Hiremath - Director, Rajendra Nath Mehrotra - Director, Manisha Girotra - Additional Director, Dinesh Charak - Addl. Director & WTD.

It is listed on the BSE with a BSE Code of 500672 and the NSE with an NSE Code of NOVARTIND.

Its Registered office is at Sandoz House, Shivsagar Estate, Dr Annie Besant Road,,Worli Mumbai,Maharashtra - 400018.

Their Registrars are Sharepro Services (India) Pvt.Ltd.

Quick Links for Novartis India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Novartis India